Injection/Infusion
ELIGARD POWDER AND SOLVENT FOR SOLUTION FOR INJECTION 22.5MG
Summary
ELIGARD POWDER AND SOLVENT FOR SOLUTION FOR INJECTION 22.5MG — Injection/Infusion containing leuprorelin acetate. Hong Kong Registration No. HK-61500. Certificate Holder: DCH AURIGA (HONG KONG) LIMITED - HEALTHCARE DIVISION. Date of Registration: 16 Oct, 2012.
Product NameELIGARD POWDER AND SOLVENT FOR SOLUTION FOR INJECTION 22.5MG
Registration No.HK-61500
Certificate HolderDCH AURIGA (HONG KONG) LIMITED - HEALTHCARE DIVISION
Holder Address(AREA A) 11/F WYLER CENTRE I, 202-210 TAI LIN PAI ROAD, KWAI CHUNG, NEW TERRITORIES
Ingredientsleuprorelin acetate
Dosage FormInjection/Infusion
Legal ClassificationPart 1, Schedule 1 & Schedule 3 Poison
Sale RequirementPrescription only Medicines
Date of Registration16 Oct, 2012
ATC codesL02AE02
ATC Classification
ATC level 1
L Antineoplastic and Immunomodulating Agents
All ATC groupsL02
本頁為藥物資料查詢工具，並非藥物廣告、推廣或醫療建議。所有資料取自香港特別行政區衞生署藥物辦公室之公開資料，僅供參考；一切以藥物辦公室官方公布為準。 本頁不提供任何療效、適應症或治療用途之陳述。用藥前請諮詢醫生或註冊藥劑師。 本網站遵守香港法例第 231 章《不良廣告（醫藥）條例》之規管。